REPLIMUNE GROUP, INC. Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Percent
REPLIMUNE GROUP, INC. (REPL) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Percent of 0.00% for the 12-month period ending 2021-03-31, per its 10-K filed 2021-05-20.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingenciesForeign · last filed 2021-05-20
- REPLIMUNE GROUP, INC. effective income tax rate reconciliation, tax contingency, foreign, percent for fiscal 2021 was 0.00%.
- REPLIMUNE GROUP, INC. effective income tax rate reconciliation, tax contingency, foreign, percent for fiscal 2020 was -2.80%.
- REPLIMUNE GROUP, INC. effective income tax rate reconciliation, tax contingency, foreign, percent for fiscal 2019 was -2.40%.
- REPLIMUNE GROUP, INC. effective income tax rate reconciliation, tax contingency, foreign, percent for fiscal 2018 was -2.20%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Percent 12 month |
|---|---|
| 2021-03-31 | 0.00% 10-K · filed 2021-05-20 |
| 2020-03-31 | -2.80% 10-K · filed 2021-05-20 |
| 2019-03-31 | -2.40% 10-K · filed 2020-06-03 |
| 2018-03-31 | -2.20% 10-K · filed 2020-06-03 |
| 2017-03-31 | -8.80% 10-K · filed 2019-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |